Skip to main content
Schizophrenia Bulletin logoLink to Schizophrenia Bulletin
. 2009 Jun 19;37(1):118–130. doi: 10.1093/schbul/sbp058

Hippocampi, Thalami, and Accumbens Microstructural Damage in Schizophrenia: A Volumetry, Diffusivity, and Neuropsychological Study

Ilaria Spoletini 2, Andrea Cherubini 2, Giulia Banfi 2, Ivo Alex Rubino 3, Patrice Peran 2, Carlo Caltagirone 2,3, Gianfranco Spalletta 3,1
PMCID: PMC3004185  PMID: 19542526

Abstract

Volumetric abnormalities in the subcortical structures have been described in schizophrenia. However, it still has to be clarified if subtle microstructural damage is also present. Thus, we aimed to detect subcortical volume and mean diffusivity (MD) alterations in 45 patients with diagnosis of schizophrenia compared with 45 age-, gender-, and educational attainment–matched healthy comparison (HC) participants, by using a combined volumetry and diffusion tensor imaging (DTI) method. A secondary aim was to identify the neuropsychological correlates of subcortical abnormalities in the schizophrenic group. We found thalami and hippocampi bilaterally and left accumbens to show MD increase in the schizophrenic group. No volumetric decrease was found. Moreover, significant correlations between the MD values in subcortical structures (right thalamus and hippocampus and left accumbens) and working memory performance were found. Thus, subcortical microstructural alterations are present in schizophrenia even in absence of volumetric abnormalities. Furthermore, microstructural damage in subcortical areas is linked to working memory, suggesting the presence of a subtle microstructural subcortical dysfunction in the pathoetiological mechanism underlying high cognitive load performances in schizophrenia. Finally, our findings indicate that MD is a more sensitive marker of brain tissue deficits than signal intensity variations measured in T1-weighted imaging data, consistently with previous reports. Thus, DTI appears to be an invaluable tool to investigate subcortical pathology in schizophrenia, greatly enhancing the ability to detect subtle brain changes in this complex disorder.

Keywords: subcortical structure, mean diffusivity, volume, working memory

Introduction

Neuroimaging studies suggest that volumetric abnormalities characterize subcortical areas, especially thalamus14 and hippocampus,5,6 in schizophrenia patients. However, it still has to be clarified if these structural alterations are associated with subtle damage in the tissue microstructure. Furthermore, because schizophrenia is a mental disorder often associated with cognitive impairment,7 it is important to clarify if subcortical volumetric and microstructural abnormalities are also associated with neuropsychological performances.

Here, we opted to use different neuroimaging techniques to provide complementary information of microstructural and volumetric changes within the subcortical areas. Particularly, because diffusion tensor imaging (DTI) is sensitive to microscopic random motion of water molecules, it is able to detect subtle microstructural abnormalities in different cerebral tissues,8,9 providing functional or physiologic information not present on conventional T1- and T2-weighted anatomic magnetic resonance (MR) images.10 An index that can be obtained by DTI is mean diffusivity (MD), a quantitative measure of directionally averaged diffusion. An increase in MD is thought to reflect an enlargement in the extracellular space due to altered cytoarchitecture, suggesting immaturity or degeneration of the tissue.11 Although DTI has been used mainly to investigate regional white matter changes, it can be also utilized to highlight microstructural alterations of subcortical gray matter,12 as demonstrated by previous reports on schizophrenia.13,14 Hence, by combining the study of atrophy/hypertrophy in MR volumetry with the potential of DTI in highlighting microstructure alterations, it should be possible to describe in detail subcortical abnormalities in schizophrenia. Furthermore, the high-resolution MR images acquired for volumetric methods should facilitate the identification of anatomical structures with limited spatial extension, such as the subcortical nuclei and gray matter structures.

Bearing these considerations in mind, the first aim of this study was to probe the volume and tissue microstructure of subcortical areas in patients with diagnosis of schizophrenia without global cognitive impairment in comparison with age-, gender-, and educational attainment–matched healthy comparison (HC) subjects. Here, the term “subcortical” is used in a broad sense to refer to the subcortical nuclei as well as to gray matter limbic regions such as amygdala and hippocampus. To our knowledge, no neuroimaging studies in schizophrenia so far have investigated subcortical microstucture and volume at the same time in these areas. In addition, in this kind of study, it is important to consider patients without global cognitive impairment because it has been described as a potential confounding variable on the subcortical volume, specifically of the hippocampus,15 and on the whole-brain volume.7,16

An optimized methodology by combining magnetic resonance imaging (MRI) volumetry and DTI was applied to the subcortical areas. In order to precisely identify the structures of interest, we employed a fully automated, model-based segmentation algorithm on MRI anatomical images and accurate coregistration of DTI to anatomical images to extract regional values of DTI parameters in these specific areas.

Following the hypothesis that the microarchitectural damage may affect the tissue in a given subcortical structure before the volumetric alterations are detectable, as preliminarily and selectively demonstrated by Kalus et al17 on the hippocampus and by Agarwal et al18 on the thalamus, we expected widespread subtle alterations in subcortical microstructural integrity (indicated by increase in MD) to characterize our sample of patients with diagnosis of schizophrenia without global cognitive impairment even in absence of volumetric abnormalities.

A secondary aim of this study was to investigate the neuropsychological correlates of MD and volume alterations in subcortical areas in the schizophrenic group. Considering that, among the other cognitive abilities, working memory and executive function are greatly impaired in schizophrenia,7,19,20 we hypothesized microstructural and/or volume abnormalities in the subcortical areas to be related to working memory and executive function domains.

Methods

Subjects

Seventy-five consecutive patients with a diagnosis of schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV)21 were initially recruited from 2 outpatient clinics in central Italy. Diagnosis of schizophrenia was independently performed by 2 clinicians, who had been trained until an interrater reliability level of k ≥ 0.80 was reached. Specifically, a clinician (I.A.R.), who treated the patients and knew their clinical history, used DSM-IV criteria to make a preliminary diagnosis of schizophrenia. The clinician was blind to the aims of the study. All diagnoses were then confirmed, or not, the day of image acquisition, by another clinical psychiatrist (G.S.) using the Structured Clinical Interview Patient Edition for DSM-IV (SCID-P).22 The second psychiatrist also screened the patients according to the inclusion and exclusion criteria of the study. In the case of disagreement between the 2 psychiatrists, more data were requested to help resolve the differences, and the diagnostic process continued until a final consensus diagnosis was assigned. If there was still disagreement among the 2 diagnosticians, the patient was removed from the sample.

Severity of schizophrenia symptoms was assessed by using the Positive and Negative Syndrome Scale (PANSS)23 (mean total PANSS score ± SD = 91.96 ± 21.87, mean positive symptoms score ± SD = 22.11 ± 7.19, mean negative symptoms score ± SD = 21.22 ± 7.73, mean general psychopathology score ± SD = 48.62 ± 12.41). Age at onset was defined as age at first hospitalization or, where possible, age at onset of positive or negative symptoms preceding the first hospitalization. All the participants included were between 18 and 66 years of age, were right-handed, and had completed at least 5 years of schooling. An inclusion criterion was the Mini-Mental State Examination (MMSE)24 score equal to or higher than 25 in order to avoid the inclusion of patients with global cognitive deterioration.

Exclusion criteria were history of alcohol or drug dependence or traumatic head injury, any past or present major medical or neurological illness (in particular, dementia diagnosis was accurately excluded by using a comprehensive neuropsychological battery, which is described in the cognitive examination section), any additional psychiatric disorder, any brain pathology identified on T2 or fluid attenuated inversion recovery scans, and mental retardation. All patients were receiving stable oral doses of one or more atypical antipsychotic drugs such as risperidone, quetiapine, and olanzapine. Antipsychotic dosages were converted to estimated equivalent dosages of olanzapine.25

From the 75 patients of the initial sample, 30 patients were excluded according to the above-mentioned exclusion criteria. Specifically, 15 patients showed global cognitive impairment (ie, a MMSE score lower than 25), 8 patients had history of alcohol and/or psychoactive drug dependence, 2 had traumatic head injury, 1 suffered from mental retardation, 2 met criteria for other psychotic disorders according to the diagnosis made by the psychiatrist who administered the SCID-P (1 delusional disorder, 1 schizoaffective disorder), and 2 patients were removed from subsequent analyses due to significant movement artifacts during the MRI procedure. Thus, the final sample consisted of 45 patients with diagnosis of schizophrenia.

Forty-five HC subjects were recruited in the same geographic area and rigorously matched with the patients with diagnosis of schizophrenia for age, gender, and educational attainment (table 1). All the HC subjects were carefully screened for a current or past diagnosis of any Axis I or II disorder using SCID-I or SCID-II, respectively.22,26 Schizophrenia or any other mental disorder diagnosis among first-degree relatives was an exclusion criterion as well as the other above-mentioned exclusion criteria for patients.

Table 1.

Sociodemographic and Clinical Characteristics of 45 Patients With Schizophrenia and 45 Healthy Comparison Subjects

Characteristics Patients With Diagnosis of Schizophrenia (N = 45) Comparison Subjects (N = 45) t df P
Mean ± SD Mean ± SD
Age (y) 39.8 ± 11.02 39.47 ± 17.10 −0.110 88 .9127
Educational level (y) 13.04 ± 2.36 13.47 ± 3.17 0.716 88 .4761
Age at the onset of the illness (y) 26.24 ± 8.37
Duration of the illness (y) 13.56 ± 10.50
Olanzapine equivalents (mg/d) 20.16 ± 32.93
N (%) N (%) χ2 df P
Gender (male) 25 (55) 25 (55) 0.000 1 >.9999
DSM-IV subtypes
    Paranoid schizophrenia 30 (67)
    Disorganized schizophrenia 2 (4)
    Undifferentiated schizophrenia 5 (11)
    Residual schizophrenia 8 (18)

Note: DSM-IV, Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition).

The study was approved and undertaken in accordance with the guidance of Santa Lucia Foundation Ethics Committee, and written consent was obtained from all participants after a full explanation of the procedures of the study.

Cognitive Examination

Two trained neuropsychologists (I.S. and G.B.), who were blind to the aims of the study, conducted the cognitive assessment, which was performed within 7 days of MRI. All the patients and HC participants underwent the cognitive examination. Forty-two out of the 45 HC subjects completed the entire neuropsychological assessment (data available upon request). Acceptable interrater reliability level for the present study was defined as of k > 0.80.

As previously mentioned, we selected a group of patients with diagnosis of schizophrenia without global cognitive impairment by administering the MMSE, as it is one of the most common instruments used to screen for cognitive deterioration. It is also brief and easy to administer and has been widely applied in research on schizophrenia.27,28MMSE provides a global index of cognitive impairment by measuring orientation, language, verbal memory, attention, visuospatial function, and mental control. It is composed of 16 items, with scores ranging from 30 (no impairment) to 0 (maximum impairment). Specific neuropsychological domains were also assessed by administering tests from the Mental Deterioration Battery (MDB).29 The MDB is a standardized and validated neuropsychological battery, comprising neuropsychological tests pertaining to the elaboration of verbal and visuospatial materials. Three tests were selected from MDB in order to provide information about the functionality of verbal memory (Rey's 15-Word Immediate Recall [RIR] and Delayed Recall [RDR]) and logical reasoning (Raven's Progressive Matrices’ 47 [PM47]). Furthermore, we used the copy of Rey-Osterrieth complex picture (ROPC) and its delayed recall,30,31 which provide information—respectively—about visual perception/constructional praxis and long-term visuospatial memory.32

Following the aims of the study, and considering that “executive functioning” denotes a set of different cognitive abilities involved in complex, goal-directed thought and behavior,33 the following executive dimensions were assessed: (a) attentional control/inhibition, (b) set shifting, and (c) working memory.

In order to measure abilities of attentional control and inhibition, we administered the Stroop Test (ST).34 The executive dimension of set shifting or cognitive flexibility, ie, the ability to alter a behavioral response mode in the face of changing contingencies, was assessed using the Modified Wisconsin Card Sorting Test (MWCST).35 Participants were also administered the Trail Making Test (TMT)36 to assess cognitive flexibility and ability to shift strategy.3739

Finally, in order to measure verbal, spatial, and visual working memory, we administered the “n-back” tasks.40 The n-back test has been widely used in previous research.4144 In this test, subjects are required to monitor continuously a sequence of verbal/spatial/visual stimuli (a total of 22 items for each task, visually presented on a screen) and to select items that appeared n-items back in any sequence (this sequence was randomly generated using locally written software installed on a Pentium 4 IBM computer). In the verbal task, stimuli consist of a series of words; in the spatial task, there is a white box that is differentially located among black boxes; and finally, in the visual task, stimuli are a series of abstract pictures.

The item selection was done by the participants using a keyboard with 3 keys, 1 for each stimulus. Also, the computer software automatically generated a file with results of the task with corrected-uncorrected responses. We administered the n-back subtasks (ie, verbal/spatial/visual) at 3 different levels of difficulty. At the “n-1 level,” subjects were required to select an item that appears 1 item back in a sequence, at the “n-2 level” to select an item that appears 2 items back in a sequence, and at the “n-3 level” to select an item that appears 3 items back in a sequence. The number of correct responses (“accuracy score”) was considered as index of working memory performance. All participants were trained to obtain their maximal performance score, using the n-1 back paradigm by means of verbal and written explanations. Training consisted in having patients practice the n-1 back sequence 3 times before starting the experimental procedure. Accuracy scores as memory load at the n-2 level for the 3 subtasks were chosen as measures in the statistical analyses, as patients scored at chance for the n-3 task and at ceiling for the n-1 task.

Image Acquisition

The 90 participants underwent the same imaging protocol with a whole-brain T1-weighted and diffusion-weighted scanning using a 3-T Allegra MR imager (Siemens, Erlangen, Germany) with a standard quadrature head coil.

Whole-brain T1-weighted images were obtained in the sagittal plane using a modified driven equilibrium Fourier transform45 sequence (echo time [TE]/repetition time [TR] = 2.4/7.92 ms, flip angle = 15°, voxel size = 1 × 1 × 1 mm3).

Diffusion-weighted images were obtained using echo planar imaging (spin-echo planar imaging, TE/TR = 89/8500 ms, 52 axial slices, bandwidth = 1860 Hz per voxel, voxel size = 1.5 × 1.5 × 3.0 mm3) with 12 isotropically distributed orientations for the diffusion-sensitizing gradients at a b value of 1000 s/mm2 and 2 b = 0 images.

All image processing was performed using FSL 4.0 software.46 Image distortions induced by eddy currents and head motion in the DTI data were corrected by applying a full affine (mutual information cost function) alignment of each image to the mean no diffusion-weighted image. Nevertheless, it should be noted that the mean b0 image used for eddy current corrections suffers from distortions itself; thus, all the typical artifacts present in echo planar images cannot be completely removed using this procedure. After distortion corrections, DTI data were averaged and concatenated into 13 (1 b0 + 12 b1000) volumes. A diffusion single-tensor model was fit at each voxel, generating MD and fractional anisotropy (FA) maps. The FA images were used to obtain a better coregistration with T1-weighted images because the spatial distribution of signal intensities was similar in both image modalities, while MD values were used as an index of structural integrity within subcortical nuclei. The FA maps created were then registered to brain-extracted whole-brain volumes from T1-weighted images using a full affine (correlation ratio cost function) alignment with nearest-neighbor resampling. The calculated transformation matrix was then applied to the MD maps with identical resampling options. For each subject, the coregistered FA map was superimposed to the original T1-weighted volume, and the resulting images were visually assessed by a trained radiologist.

Image Processing.

Anatomical T1-weighted images were processed with the segmentation tool FIRST 1.047 integrated within the FSL software. FIRST (http://www.fmrib.ox.ac.uk/fsl/first/index.html) is a completely automatic, model-based segmentation/registration tool. The shape/appearance models used in FIRST are constructed from manually segmented images provided by the Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA. The manual labels are parameterized as surface meshes and modeled as a point distribution model. Deformable surfaces are used to automatically parameterize the volumetric labels in terms of meshes; the deformable surfaces are constrained to preserve vertex correspondence across the training data. Furthermore, normalized intensities along the surface normals are sampled and modeled. The shape-and-appearance model is based on multivariate Gaussian assumptions. Shape is then expressed as a mean with modes of variation (principal components). Based on learned models, FIRST searches through linear combinations of shape modes of variation for the most probable shape instance given the observed intensities in the T1 image. FIRST uses mesh models trained with a large amount of rich hand-segmented training data to segment subcortical structures. This method of segmentation is particularly useful for structures with low contrast-to-noise ratio. In each subject, the lateral ventricles, caudate, thalamus, hippocampus, putamen, accumbens, pallidum, and amygdala were segmented. For each subject, the segmentation results were visually assessed by a trained radiologist.

For each subject and each hemisphere, we calculated the volumes of the 8 above-mentioned segmented subcortical areas. Before statistical comparison, individual volume values were multiplied by a normalization factor obtained with the SIENAX tool48 from the corresponding T1-weighted image. A 2-sample t test was performed in order to verify that the 2 groups did not differ for the normalization factor (P = .8867, t = −0.1429, SD = 0.0356, Cohen d = 0.0299).

These segmented structures defined the region of interest from where mean and SD of MD values were calculated for each individual and for each hemisphere.

Statistical Analyses

Data from all 90 subjects were included in statistical analyses. Comparisons between the 2 groups on age and educational level were performed using t tests. Comparison between the 2 groups on gender variable was performed using the χ2 test.

In order to minimize the likelihood of type I error, a series of univariate analyses of variance (ANOVAs) was preceded by overall multivariate analysis of variance (MANOVA) using all the continuous categories considered in each of the analyses as dependent variables. Consequently, 1-way ANOVAs (between groups) were run for each volume and diffusivity parameter of each area. A level of significance of P < .05 for comparative measurements was used throughout the study.

Correlation Between Subcortical Volume, MD, and Neuropsychological Scores in the Schizophrenic Group.

Given the large number of neuropsychological variables here assessed (ie, 12), the principal component analysis (PCA) was used as the extraction procedure to identify underlying neuropsychological factors, after conversion of raw test scores into standard equivalents (ie, z scores) using test means and SDs. Bartlett index of sphericity was checked to assess the appropriateness of factor analysis. Eigenvalues ≥1 were used as guides to establish the number of factors. Factor loadings greater than 0.50 were added. An orthogonal rotational procedure (varimax) enabled the improvement of the interpretation of factors. In order to make the underlying factor structure clearer, by extracting as high differences between the variables as possible, an additional transformation, the orthotran transformation, was applied.49,50 Two matrices were generated: the “primary pattern matrix” and the “reference structure matrix.” The reference structure matrix was chosen because it shows by definition correlations among variables in a clearer way.49

Factorial scores were saved for successive analysis. Univariate correlation analyses (Pearson r) and Fisher's r-to-z transformation were then computed between the cognitive factors yielded by the PCA and the diffusivity and volume scores previously found to differentiate patients and controls.

Results

As expected from the matching procedure, patients with diagnosis of schizophrenia and HC subjects did not significantly differ for age, gender, and educational attainment (table 1).

Volumetric and DTI Data

An automatic segmentation method47 was used for delineating the lateral ventricles and 7 subcortical structures (thalamus, hippocampus, caudate, putamen, pallidum, amygdala, and accumbens) on each subject (see figure 1).

Fig. 1.

Fig. 1.

Example of Regions of Interest Mapped Onto a Subject's T1-Weighted Magnetic Resonance Imaging Images. The anatomical structures segmented on the T1-weighted image were subsequently mapped on the diffusion tensor imaging–derived images in order to extract regional diffusivity values.

In table 2, MD values of the subcortical structures are reported. A MANOVA using all the MD scores as dependent variables (Wilks λ = 0.712; F = 2.172; df = 14,75; P = .0167) and a series of follow-up 1-way ANOVAs revealed a significant increase of MD in the right and left thalami, right and left hippocampi, and left accumbens in patients with diagnosis of schizophrenia compared with HC subjects, as shown in figure 2.

Table 2.

Mean Diffusivity (×10−6 mm2/s) of the Subcortical Areas in 45 Patients With Diagnosis of Schizophrenia and 45 HC Subjects

Structures Side Patients With Diagnosis of Schizophrenia HC Subjects ANOVA
Mean (SD) Mean (SD) F (df: 1,88) P Cohen d
Thalamus Right 870 (33) 851 (42) 5.63 .0198 0.50
Left 845 (29) 824 (35) 10.07 .0021 0.67
Hippocampus Right 984 (54) 948 (35) 14.36 .0003 0.80
Left 993 (53) 954 (34) 17.05 <.0001 0.87
Caudate Right 998 (104) 964 (101) 2.56 .1129 0.34
Left 930 (79) 904 (76) 2.58 .1117 0.34
Putamen Right 769 (41) 761 (43) 0.83 .3636 0.19
Left 759 (37) 749 (29) 1.89 .1731 0.29
Pallidum Right 728 (68) 742 (44) 1.35 .2488 −0.24
Left 730 (56) 744 (48) 1.69 .1975 −0.27
Amygdala Right 971 (80) 954 (68) 1.18 .2796 0.23
Left 945 (67) 929 (60) 1.32 .2536 0.24
Accumbens Right 771 (62) 754 (52) 1.97 .1641 0.30
Left 772 (60) 742 (46) 7.02 .0095 0.56

Note: Significant P values (P < 0.05) are indicated in bold. HC, healthy comparison; ANOVA, analysis of variance.

Fig. 2.

Fig. 2.

Average Reconstruction of the Subcortical Regions That Showed Significant Group Differences Between Patients and Healthy Controls. The bar graphs report the average mean diffusivity values (×10−6 mm2/s) and SEs for individual left or right structures.

In table 3, subcortical volumes are indicated. A MANOVA using all the subcortical volume scores as dependent variables indicated that volumes of subcortical areas were globally different between patients and HC subjects (Wilks λ = 0.692; F = 2.030; df = 16,73; P = .0219). However, a series of follow-up 1-way ANOVAs revealed no volumetric decrease in patients with diagnosis of schizophrenia as compared with HC subjects. On the contrary, we found increased volumes in the left accumbens. Interestingly, left ventricle was enlarged in patients with diagnosis of schizophrenia.

Table 3.

Normalized Volumes (mm3) of the Subcortical Areas in 45 Patients With Diagnosis of Schizophrenia and 45 HC Subjects

Area Side Patients With Diagnosis of Schizophrenia HC Subjects ANOVA
Mean (SD) Mean (SD) F (df: 1,88) P Cohen d
Lateral ventricles Right 6445 (2892) 5505 (3421) 1.98 .1629 0.30
Left 6795 (3395) 5445 (2916) 4.09 .0460 0.43
Thalamus Right 6107 (730) 6308 (666) 1.85 .1770 −0.29
Left 5697 (706) 5979 (706) 3.60 .0612 −0.40
Hippocampus Right 2560 (365) 2630 (297) 0.98 .3237 −0.21
Left 2401 (285) 2452 (318) 0.64 .4255 −0.17
Caudate Right 2738 (422) 2610 (471) 1.85 .1777 0.29
Left 2670 (460) 2556 (460) 1.37 .2441 0.25
Putamen Right 3782 (472) 3725 (428) 0.37 .5461 0.13
Left 3619 (521) 3634 (489) 0.02 .8917 −0.03
Pallidum Right 1026 (228) 1092 (180) 2.29 .1338 −0.32
Left 1044 (184) 1056 (150) 0.11 .7388 −0.07
Amygdala Right 818 (155) 813 (190) 0.02 .9011 −0.03
Left 750 (147) 806 (169) 2.81 .0969 −0.35
Accumbens Right 235 (73) 215 (81) 1.53 .2189 0.26
Left 320 (98) 281 (87) 3.98 .0491 0.42

Note: Significant P values (P < 0.05) are indicated in bold. HC, healthy comparison, ANOVA, analysis of variance.

Furthermore, 2 additional MANOVAs for both MD and volume values were performed. In a first MANOVA, values from left and right brain subcortical structure averaged (ie, a sum of each bilateral structure divided by 2) were used in order to explore whether the means differed across groups. In a second MANOVA, we used the “differenced values” (ie, obtained by subtracting left brain subcortical values from right values) in order to further explore whether hemispheric asymmetry differed across groups. Consistently with our previous results, averaged left and right brain subcortical values were significantly different between patients and HC groups for both MD and volume values, respectively (Wilks λ = 0.772; F = 3.462; df = 7,82; P = .0027; and Wilks λ = 0.810; F = 2.370; df = 8,81; P = .0240). A series of follow-up 1-way ANOVAs revealed a significant increase of MD in the averaged thalami, hippocampi, and accumbens of patients, whereas no individual volumetric differences were found in patients with diagnosis of schizophrenia compared with HC subjects (data available upon request). On the other hand, the results from the other two MANOVAs showed no significant differences between patients and HC groups for the differenced MD and volume values (P > .175 for both comparisons).

Cognitive Correlates of Subcortical Abnormalities in Schizophrenia

Neuropsychological scores were computed by using a PCA, incorporating the 12 above-described neuropsychological scores. PCA extracted 4 factors with eigenvalues greater than 1, representing a total of 77.4% of the variance. The orthotran transformation generated 2 matrices. As expected, factors in the reference structure matrix were equivalent to those generated using the primary pattern matrix, in the sense that the same variables fitted in the same factors. This is intuitive because one is a column rescaling of the other.49 We considered as results the factors shown by the reference structure matrix, which is reported in table 4.

Table 4.

Principal Component Analysis of the Neuropsychological Variables in 45 Patients With Diagnosis of Schizophrenia: Orthotran Reference Structure Matrix

Variables Independent Dimensions
Factor 1 (Working Memory) Factor 2 (Verbal Memory) Factor 3 (Executive Function) Factor 4 (Visuospatial Abilities)
RIR 0.036 0.859 0.034 0.049
RDR −0.041 0.881 −0.100 −0.121
PM47 −0.062 −0.139 7.9 × 10−5 0.853
TMT ratio score 0.059 −0.071 0.550 −0.138
ROPC −0.030 −0.052 −0.016 0.777
ROPR 0.191 0.298 0.051 0.435
ST interference time −0.113 −0.097 0.128 −0.510
MWCST, achieved categories −0.097 −1.8 × 10−4 −0.867 −0.005
MWCST, perseverative errors −0.146 0.042 0.736 0.081
n-2 back verbal 0.809 −0.030 −0.038 −0.009
n-2 back visual 0.793 0.019 −0.002 0.035
n-2 back spatial 0.796 0.023 2.0 × 10−4 0.029
Eigenvalues 4.983 1.657 1.387 1.262
Variance proportion 0.415 0.138 0.116 0.105

Note: RIR, Rey's 15-Word Immediate Recall; RDR, Rey's 15-Word Delayed Recall; PM47, Raven's Progressive Matrices’ 47; TMT, Trail Making Test; ROPC, Rey-Osterrieth complex picture; ROPR, delayed recall of Rey-Osterrieth complex picture; ST, Stroop Test; MWCST, Modified Wisconsin Card Sorting Test. Variables fitted in factors are indicated in bold.

The first factor, which represents the “working memory” domain, accounted for 41.5% of total score variance and was composed by the n-2 back verbal, spatial, and visual tasks; the second factor, which represents the “verbal memory” domain, accounted for 13.8% of score variance and was composed by RIR and RDR; the third factor, which represents the executive functioning domain, accounted for 11.6% of total score variance and was composed by TMT ratio score, MWCST-achieved categories, and MWCST perseverative errors; and finally, the fourth factor was a residual domain that accounted for 10.5% of total score variance and was composed by heterogeneous tests measuring logical reasoning (PM47), visual perception/constructional praxis (ROPC), and attentional control and inhibition (ST interference time). It was called for convenience “visuospatial abilities” because all the 3 tests included required visuospatial abilities to complete them. Univariate correlation analyses were then computed between the 4 neuropsychological domains and the diffusivity and volume scores previously found to differentiate patients and controls.

Results of the correlation analyses are indicated in table 5. Correlation analyses showed that working memory domain was significantly and negatively correlated to MD score in right thalamus, right hippocampus, and left accumbens, with trend-level (P < .1) relationships observed with MD of the left hippocampus and with volume of the left ventricle. No other significant or trend-level relationships were observed between other neuropsychological domains and MD or volume values in the schizophrenic group.

Table 5.

Relationships Between Subcortical MD or Volume Values, Found to be Altered in the Schizophrenia Group, and 4 Neuropsychological Domain Factors, as Emerged From the Univariate Correlation Analysis

Cognitive Domains Pearson r (P Value)
Right Thalamus MD Left Thalamus MD Right Hippocampus MD Left Hippocampus MD Left Accumbens MD Left Accumbens Volume Left Ventricle Volume
Working memory −0.457 (.0014) −0.188 (.2164) −0.337 (.0231) −0.262 (.0817) −0.361 (.0142) −0.178 (.2443) −0.273 (.0691)
Verbal memory 0.122 (.4252) −0.133 (.3846) −0.003 (.9819) −0.063 (.6826) 0.027 (.8590) −0.115 (.4538) −0.121 (.4299)
Executive function 0.032 (.8354) −0.198 (.1931) −0.237 (.1174) −0.233 (.1237) −0.124 (.4186) −0.041 (.7886) 0.107 (.4858)
Visuospatial abilities −0.064 (.6781) −0.027 (.8604) −0.135 (.3789) −0.237 (.1177) −0.075 (.6249) 0.035 (.8211) −0.020 (.8989)

Note: Working memory accuracy decreased as MD values increased in right thalamus, right hippocampus, and left accumbens. MD, mean diffusivity. Significant P values (P ≤ .05) are indicated in bold. Trend-level significant P values (P < .1) are indicated in italics.

Discussion

Combining volumetry and microstructure (DTI-MD) analyses of subcortical areas, we found significant increased MD values in thalami and hippocampi of both sides and in left accumbens. Volumetric changes, in the only direction of hypertrophy, were detectable in the left accumbens, and no subcortical atrophy was found. Furthermore, left lateral ventricle was enlarged in our sample of patients with diagnosis of schizophrenia without global cognitive impairment. The significant correlations between working memory domain and the MD values in right thalamus, right hippocampus, and left accumbens confirm the functional significance in terms of neuropsychological performance of the altered subcortical microstructure.

Here, we discuss how these findings point toward a model that emphasizes the presence of subtle, and potentially precocious, subcortical microstructural abnormalities in schizophrenia and their link with performances of high cognitive load level—such as working memory—in patients with diagnosis of schizophrenia.

Volume and Microstructural Abnormalities in Patients With Schizophrenia

Result of increased MD in thalami and hippocampi in absence of significant subcortical volume atrophy suggests the presence, even in patients with diagnosis of schizophrenia with unimpaired global cognition, of subtle abnormalities only at a microstructural level in these areas. This is in line with neuroimaging and postmortem studies that have described microstructural and histological abnormalities in the thalamus51,52 and in the hippocampal formation in schizophrenia.53,54 To our knowledge, there are only 2 previous neuroimaging studies, focusing selectively on hippocampus17 and thalamus18 in patients with schizophrenia, suggesting that, in absence of morphological abnormalities, these 2 subcortical areas present microstructural abnormalities, ie, intervoxel coherences decrease and apparent diffusion coefficient increases, respectively. However, the anatomical areas investigated in these 2 studies were limited to one subcortical structure for each report, and the fine neuropsychological level was not considered. Thus, here, we provide the first evidence, to our knowledge, indicating that there are some subcortical areas that present microstructural abnormalities in absence of volume reduction in a large sample of patients with schizophrenia.

Our MD findings are also consistent with postmortem studies on schizophrenia, which have described a reduced total number of neurons and decreased volume in the thalamus (eg, ventral lateral posterior nucleus55; mediodorsal and anterior nuclei56,57). As for the hippocampus, the abnormalities include a decrease in area or whole volume of the hippocampus, a decrease in the number of hippocampal neurons, reduced neuronal size and density, and pyramidal cell disarray.54 Interestingly, increased MD may be considered as a marker of a reduced number of cells and increased extracellular space.11 Therefore, we speculate that our findings of increased hippocampal and thalamic MD may reflect cell loss and impaired structural integrity in such subcortical regions in schizophrenia.

Consistently, thalamus and hippocampus are thought to play a pivotal role in the physiopathology of schizophrenia.3,58 As for the thalamus, our finding fits very well with model of thalamocortical dysfunction as a key component of etiopathological mechanism underlying cognitive and also clinical symptoms in schizophrenia.1,59,60 Indeed, disruptions in thalamic circuitries such as the cortico-striatal-thalamo-cortical as well as the cortico-cerebellar-thalamo-cortical networks have been proposed, by Andreasen et al,61 to lead to cognitive dysmetria, accounting for deficits in managing and performing information-processing tasks. However, previous studies used to build this model included subjects who were not selected for cognitive level and used thalamic volume or metabolism as an index of structural-functional abnormality. Interestingly, in our patient sample without global cognitive deterioration or dementia, we found that only a fine index of thalamic gray matter microstructure, such as MD, was abnormal, and this modification was negatively associated with working memory performance, which overlaps those abilities in managing, coordinating, and performing information-processing tasks described by Andreasen et al.60

Hippocampus, as well as the thalamus, has been considered to be involved in the pathogenesis of schizophrenia, on the basis of evidence from neuroimaging, animal model, and histological studies.54,62 Indeed, because hippocampus has been described as a pivotal anatomical component of the aberrant schizophrenia functional connectivity,63,64 we can speculate that the altered microstructure in the hippocampi highlighted in our study may lead to disturbed information flow between the limbic circuit and the prefrontal cortex. This hypothesis is substantiated by a recent animal study65 that suggests that the dysfunction of information processing observed in patients with diagnosis of schizophrenia arises in part from a disturbed dopaminergic regulation among the hippocampus, accumbens, and prefrontal cortex. Consistently, we have found both increased MD and volume in the left accumbens in our sample of patients with diagnosis of schizophrenia. The increased volume in the accumbens is in line with postmortem studies in schizophrenia6668 and is thought to reflect a decrease in naturally occurring cell death following prenatal cortical neurodevelopmental disturbances.68 Thus, the results of our study also provide the first evidence, to our knowledge, of altered accumbal MD in schizophrenia, which gives further support to the hypothesis proposing an important role for this structure in schizophrenia pathophysiology.69,70

Taken all together, our DTI and volumetry results indicate that it is important to investigate in schizophrenia the presence of subtle microstructural changes localized in subcortical areas, such as thalami, hippocampi, and accumbens, which have been understood as key targets of pathophysiological processes in this disorder. Because thalamic volume reduction was found in some, but not all, studies in schizophrenia71 and hippocampal volume may depend on the psychosis diagnosis and stage,72 as well as on the cognitive level,15 it seems that altered subcortical microstructure, rather than the volumetry, may be a more consistent hallmark of subcortical pathology in schizophrenia.

Finally, we found increased left lateral ventricle volume in our schizophrenic group. Left-lateralized ventricular enlargement is one of the earliest73 and more consistent reported abnormalities in schizophrenia.74 Left ventricular enlargement is commonly thought to reflect diffuse brain atrophy more prominent in the left side,75 but it may also be linked to volume reduction of adjacent subcortical regions (eg, left thalamus).76 The greater enlargement seen on the left than on the right side may indicate that ventricular enlargement is, in part, a lateralized process, thereby supporting the hypothesis that schizophrenia is a disease of asymmetry.73 However, this topic is far from being defined with certainty and warrants further investigation particularly in subcortical areas, as indicated by the lack of statistical significance in analyses performed with scores obtained subtracting left-side brain subcortical structure values from right-side structure values.

Neuropsychological Correlates of Subcortical Microstructural Damage in Patients With Diagnosis of Schizophrenia Without Global Cognitive Impairment

In order to identify the functional meaning, in terms of neuropsychological performance, of subcortical abnormalities in the schizophrenic group, we analyzed the relationships between MD and volume values found to be different between case-control groups and neuropsychological domains. We found that increased working memory performance was related to microstructure integrity, measured in terms of MD, in the right thalamus, right hippocampus, and left accumbens, with also some relationships at a trend level with left hippocampus and volume of left ventricle.

These findings fit very well with the hypotheses that consider subcortical structures to play a crucial role in working memory performance, in view of their connections with the brain cortices, not only at the prefrontal level77 but also at the parietal and temporal levels.78 Indeed, research on schizophrenia has identified a distributed network of cortical and subcortical regions involved in working memory,7981 particularly empathizing the role of the frontostriatal dopaminergic circuits.20,79 For instance, attention, an important component of working memory,82 is thought to be subserved by a mostly right-lateralized frontal, parietal, and thalamic network.83 Thus, our result of working memory domain as mainly related to right-lateralized thalamic and hippocampal microstructural damage provides additional evidence on the role of the right hemisphere in cognition in schizophrenia, as efficaciously summarized by Mitchell and Crow.84 On the other hand, results indicating the trend-level relationships between working memory performance and enlarged left ventricle and left hippocampal MD seem to suggest a bilateral involvement of brain structures and functions in schizophrenia.

Furthermore, our data indicate that this neuropsychological corticosubcortical model emerging from previous research in schizophrenia7981 might be further developed. More subtle microstructural subcortical changes seem to play a key role in working memory function. Our findings suggest that this ability of high cognitive load level is subserved by a distributed cortical-subcortical network that includes structures such as thalamus, hippocampus, and accumbens that are altered in their microstructures in patients with diagnosis of schizophrenia. Consequently, reduced working memory performances in schizophrenia are not necessarily related to subcortical volumetric abnormalities but rather to more subtle microstructural alterations.

Strengths and Limitations of the Study and Conclusions

To the best of our knowledge, this is the first study applying a combined volumetry and DTI method on subcortical nuclei in the same sample of patients with diagnosis of schizophrenia. Also, we provide the first evidence on the neuropsychological correlates of microstructural abnormalities in the subcortical nuclei in schizophrenia.

Nevertheless, some limitations need to be drawn for the generalization of the results. Firstly, all patients with diagnosis of schizophrenia in our study received cumulative doses of atypical antipsychotics, whose influence on the results must be taken into consideration.85,86 However, performing a series of univariate correlation analyses, we failed to find any relationship between antipsychotic dosages and subcortical MD or volume values in our sample, with the exception of a weak and not significant correlation with MD score in the left hippocampus (data available upon request). Therefore, we exclude a relevant confounding effect of medication on our results. However, follow-up studies in larger cohorts of drug-naive, first-episode schizophrenic subjects are required to explore the full potential use of combining DTI with volumetry on subcortical nuclei.

Secondly, further studies are necessary to clarify the link between subcortical, microstructural, and volumetric abnormalities and clinical symptoms in schizophrenia, which was not among the aims of the present study. Thirdly, we chose to include in our study only schizophrenic patients without global cognitive impairment as assessed by MMSE on the basis of previous evidence that global cognitive impairment may act as a potential confounding variable on volumes of subcortical brain structures. However, it could be argued that our MMSE cutoff score could have excluded patients who were most impaired in other cognitive domains. To test this hypothesis, we performed a series of univariate correlation analyses and found only weak and nonsignificant correlations between the MMSE score and the neuropsychological domains: working memory (r = 0.252, P = .0953), verbal memory (r = 0.275, P = .0670), executive function (r = 0.069, P = .6564), and visuospatial abilities (r = 0.291, P = .0517). Thus, it is not very probable that this limitation may compromise the generalization of our results.

In conclusion, this study was able to highlight subtle microstructural damage in subcortical areas present even in absence of detectable volumetric changes in patients with diagnosis of schizophrenia without global cognitive deterioration. The microstructural alterations in subcortical regions, ie, hippocampus, thalamus, and left accumbens, play a pivotal role in working memory performances.

Finally, our findings indicate that MD is a more sensitive marker of brain tissue deficits than signal intensity variations measured in T1-weighted imaging data, consistently with previous reports.13 This is intriguing, also considering the great variability across volumetric studies in schizophrenia.87 Thus, DTI appears to be an invaluable tool to investigate subcortical pathology in schizophrenia, greatly enhancing the ability to detect subtle brain changes in this complex disorder.

Funding

Italian Ministry of Health (RC06-07-08/A grants).

References

  • 1.Byne W, Hazlett EA, Buchsbaum MS, Kemether E. The thalamus and schizophrenia: current status of research. Acta Neuropathol. 2009;117:367–368. doi: 10.1007/s00401-008-0404-0. [DOI] [PubMed] [Google Scholar]
  • 2.Danos P, Schmidt A, Baumann B, et al. Volume and neuron number of the mediodorsal thalamic nucleus in schizophrenia: a replication study. Psychiatry Res. 2005;140:281–289. doi: 10.1016/j.pscychresns.2005.09.005. [DOI] [PubMed] [Google Scholar]
  • 3.Ananth H, Popescu I, Critchley HD, Good CD, Frackowiak RS, Dolan RJ. Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am J Psychiatry. 2002;159:1497–1505. doi: 10.1176/appi.ajp.159.9.1497. [DOI] [PubMed] [Google Scholar]
  • 4.Crespo-Facorro B, Roiz-Santianez R, Pelayo-Teran JM, et al. Reduced thalamic volume in first-episode non-affective psychosis: correlations with clinical variables, symptomatology and cognitive functioning. NeuroImage. 2007;35:1613–1623. doi: 10.1016/j.neuroimage.2007.01.048. [DOI] [PubMed] [Google Scholar]
  • 5.Meisenzahl EM, Koutsouleris N, Bottlender R, et al. Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr Res. 2008;104:44–60. doi: 10.1016/j.schres.2008.06.023. [DOI] [PubMed] [Google Scholar]
  • 6.Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry. 2000;157:16–25. doi: 10.1176/ajp.157.1.16. [DOI] [PubMed] [Google Scholar]
  • 7.Crespo-Facorro B, Barbadillo L, Pelayo-Teran JM, Rodriguez-Sanchez JM. Neuropsychological functioning and brain structure in schizophrenia. Int Rev Psychiatry. 2007;19:325–336. doi: 10.1080/09540260701486647. [DOI] [PubMed] [Google Scholar]
  • 8.Basser PJ. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed. 1995;8:333–344. doi: 10.1002/nbm.1940080707. [DOI] [PubMed] [Google Scholar]
  • 9.Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B. 1996;111:209–219. doi: 10.1006/jmrb.1996.0086. [DOI] [PubMed] [Google Scholar]
  • 10.Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401–407. doi: 10.1148/radiology.161.2.3763909. [DOI] [PubMed] [Google Scholar]
  • 11.Sykova E. Extrasynaptic volume transmission and diffusion parameters of the extracellular space. Neuroscience. 2004;129:861–876. doi: 10.1016/j.neuroscience.2004.06.077. [DOI] [PubMed] [Google Scholar]
  • 12.Muller MJ, Greverus D, Weibrich C, et al. Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI. Neurobiol Aging. 2007;28:398–403. doi: 10.1016/j.neurobiolaging.2006.01.009. [DOI] [PubMed] [Google Scholar]
  • 13.Narr KL, Hageman N, Woods RP, et al. Mean diffusivity: a biomarker for CSF-related disease and genetic liability effects in schizophrenia. Psychiatry Res. 2009;171:20–32. doi: 10.1016/j.pscychresns.2008.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ardekani BA, Bappal A, D'Angelo D, et al. Brain morphometry using diffusion-weighted magnetic resonance imaging: application to schizophrenia. Neuroreport. 2005;16:1455–1459. doi: 10.1097/01.wnr.0000177001.27569.06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Toulopoulou T, Grech A, Morris RG, et al. The relationship between volumetric brain changes and cognitive function: a family study on schizophrenia. Biol Psychiatry. 2004;56:447–453. doi: 10.1016/j.biopsych.2004.06.026. [DOI] [PubMed] [Google Scholar]
  • 16.Antonova E, Sharma T, Morris R, Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res. 2004;70:117–145. doi: 10.1016/j.schres.2003.12.002. [DOI] [PubMed] [Google Scholar]
  • 17.Kalus P, Buri C, Slotboom J, et al. Volumetry and diffusion tensor imaging of hippocampal subregions in schizophrenia. Neuroreport. 2004;15:867–871. doi: 10.1097/00001756-200404090-00027. [DOI] [PubMed] [Google Scholar]
  • 18.Agarwal N, Rambaldelli G, Perlini C, et al. Microstructural thalamic changes in schizophrenia: a combined anatomic and diffusion weighted magnetic resonance imaging study. J Psychiatry Neurosci. 2008;33:440–448. [PMC free article] [PubMed] [Google Scholar]
  • 19.Bonelli RM, Cummings JL. Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci. 2007;9:141–151. doi: 10.31887/DCNS.2007.9.2/rbonelli. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Koch K, Wagner G, Nenadic I, et al. Fronto-striatal hypoactivation during correct information retrieval in patients with schizophrenia: an fMRI study. Neuroscience. 2008;153:54–62. doi: 10.1016/j.neuroscience.2008.01.063. [DOI] [PubMed] [Google Scholar]
  • 21.American Psychiatric Association. 4th ed. Washington, DC: Diagnostic and Statistical Manual of Mental Disorders. Author; 2004. [Google Scholar]
  • 22.First MB, Spitzer RL, Gibbon M, Williams JB. Washington, DC: American Psychiatric Press; 1997. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version. [Google Scholar]
  • 23.Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–276. doi: 10.1093/schbul/13.2.261. [DOI] [PubMed] [Google Scholar]
  • 24.Folstein MF, Folstein SE, McHugh PR. ”Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  • 25.Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64:663–667. doi: 10.4088/jcp.v64n0607. [DOI] [PubMed] [Google Scholar]
  • 26.First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. Washington, DC: American Psychiatric Press; 1997. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) [Google Scholar]
  • 27.Ganguli R, Brar JS, Vemulapalli H, et al. Mini-Mental State Examination (MMSE) performance of partially remitted community-dwelling patients with schizophrenia. Schizophr Res. 1998;33:45–52. doi: 10.1016/s0920-9964(98)00044-9. [DOI] [PubMed] [Google Scholar]
  • 28.Moore DJ, Palmer BW, Jeste DV. Use of the mini-mental state exam in middle-aged and older outpatients with schizophrenia: cognitive impairment and its associations. Am J Geriatr Psychiatry. 2004;12:412–419. doi: 10.1176/appi.ajgp.12.4.412. [DOI] [PubMed] [Google Scholar]
  • 29.Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol. 1996;36:378–384. doi: 10.1159/000117297. [DOI] [PubMed] [Google Scholar]
  • 30.Rey A. L'examen psychologie dan les cas d'encéphalopathie traumatique (Les problèmes) Arch Psychol. 1941;28:286–340. [Google Scholar]
  • 31.Osterrieth PA. Le test de copie d'une figure complexe. Arch Psychol. 1944:206–356. [Google Scholar]
  • 32.Knight JA, Kaplan E. The Handbook of Rey-Osterrieth Complex Figure Usage: Clinical and Research Applications. Odessa, FL: Psychological Assessment Resources; 2003. [Google Scholar]
  • 33.Kerns JG, Nuechterlein KH, Braver TS, Barch DM. Executive functioning component mechanisms and schizophrenia. Biol Psychiatry. 2008;64:26–33. doi: 10.1016/j.biopsych.2008.04.027. [DOI] [PubMed] [Google Scholar]
  • 34.Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643–662. [Google Scholar]
  • 35.Heaton RK, Chelune GJ, Talley JL, Kay GC, Curtiss G. Wisconsin Card Sorting Test. Manual. Odessa, FL: Psychological Assessment Resources; 1993. [Google Scholar]
  • 36.Reitan RM, Wolfson D. Tempe, AZ: Neuropsychology Press; 1985. The Halstead-Reitan Neuropsychological Test Battery. [Google Scholar]
  • 37.Reitan RM. Tucson, AZ: Reitan Neuropsychology Laboratories, Inc; 1978. Manual for Administration of Neuropsychological Test Batteries for Adults and Children. [Google Scholar]
  • 38.Reitan RM, Wolfson D. Tucson, AZ: Neuropsychology Press; 1993. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. [Google Scholar]
  • 39.Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol. 2000;22:518–528. doi: 10.1076/1380-3395(200008)22:4;1-0;FT518. [DOI] [PubMed] [Google Scholar]
  • 40.Braver TS, Cohen JD, Nystrom LE, Jonides J, Smith EE, Noll DC. A parametric study of prefrontal cortex involvement in human working memory. NeuroImage. 1997;5:49–62. doi: 10.1006/nimg.1996.0247. [DOI] [PubMed] [Google Scholar]
  • 41.Oliveri M, Turriziani P, Carlesimo GA, et al. Parieto-frontal interactions in visual-object and visual-spatial working memory: evidence from transcranial magnetic stimulation. Cereb Cortex. 2001;11:606–618. doi: 10.1093/cercor/11.7.606. [DOI] [PubMed] [Google Scholar]
  • 42.Owen AM, Stern CE, Look RB, Tracey I, Rosen BR, Petrides M. Functional organization of spatial and nonspatial working memory processing within the human lateral frontal cortex. Proc Natl Acad Sci U S A. 1998;95:7721–7726. doi: 10.1073/pnas.95.13.7721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Smith EE, Jonides J. Working memory: a view from neuroimaging. Cogn Psychol. 1997;33:5–42. doi: 10.1006/cogp.1997.0658. [DOI] [PubMed] [Google Scholar]
  • 44.Spalletta G, Tomaiuolo F, Di Paola M, et al. The neuroanatomy of verbal working memory in schizophrenia: a voxel-based morphometry study. Clin Schizophr Relat Psychoses. 2008;2:79–87. [Google Scholar]
  • 45.Deichmann R, Schwarzbauer C, Turner R. Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T. NeuroImage. 2004;21:757–767. doi: 10.1016/j.neuroimage.2003.09.062. [DOI] [PubMed] [Google Scholar]
  • 46.Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage. 2004;23(suppl 1):S208–S219. doi: 10.1016/j.neuroimage.2004.07.051. [DOI] [PubMed] [Google Scholar]
  • 47.Patenaude B, Smith S, Kennedy D, Jenkinson M. Presented at: Thirteenth Annual Meeting of the Organization for Human Brain Mapping—HBM; June 10–16, 2007; Chicago, IL. 2007. FIRST—FMRIB's Integrated Registration and Segmentation Tool. [Google Scholar]
  • 48.Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage. 2002;17:479–489. doi: 10.1006/nimg.2002.1040. [DOI] [PubMed] [Google Scholar]
  • 49.Hofmann RJ. The orthotran solution. Multivariate Behav Res. 1978;13:99–124. doi: 10.1207/s15327906mbr1301_7. [DOI] [PubMed] [Google Scholar]
  • 50.Ramsay JO, Silverman BW. Functional Data Analysis. New York, NY: Springer-Verlag; 1997. [Google Scholar]
  • 51.Rose SE, Chalk JB, Janke AL, et al. Evidence of altered prefrontal-thalamic circuitry in schizophrenia: an optimized diffusion MRI study. NeuroImage. 2006;32:16–22. doi: 10.1016/j.neuroimage.2006.03.003. [DOI] [PubMed] [Google Scholar]
  • 52.Clinton SM, Meador-Woodruff JH. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophr Res. 2004;69:237–253. doi: 10.1016/j.schres.2003.09.017. [DOI] [PubMed] [Google Scholar]
  • 53.Casanova MF, Rothberg B. Shape distortion of the hippocampus: a possible explanation of the pyramidal cell disarray reported in schizophrenia. Schizophr Res. 2002;55:19–24. doi: 10.1016/s0920-9964(01)00201-8. [DOI] [PubMed] [Google Scholar]
  • 54.Gothelf D, Soreni N, Nachman RP, et al. Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia. Eur Neuropsychopharmacol. 2000;10:389–395. doi: 10.1016/s0924-977x(00)00097-3. [DOI] [PubMed] [Google Scholar]
  • 55.Danos P, Baumann B, Bernstein HG, et al. The ventral lateral posterior nucleus of the thalamus in schizophrenia: a post-mortem study. Psychiatry Res. 2002;114:1–9. doi: 10.1016/s0925-4927(01)00131-7. [DOI] [PubMed] [Google Scholar]
  • 56.Byne W, Buchsbaum MS, Mattiace LA, et al. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry. 2002;159:59–65. doi: 10.1176/appi.ajp.159.1.59. [DOI] [PubMed] [Google Scholar]
  • 57.Young KA, Manaye KF, Liang C, Hicks PB, German DC. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry. 2000;47:944–953. doi: 10.1016/s0006-3223(00)00826-x. [DOI] [PubMed] [Google Scholar]
  • 58.Schmajuk NA. Hippocampal dysfunction in schizophrenia. Hippocampus. 2001;11:599–613. doi: 10.1002/hipo.1074. [DOI] [PubMed] [Google Scholar]
  • 59.Rusch N, Spoletini I, Wilke M, et al. Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia. Schizophr Res. 2007;93:79–89. doi: 10.1016/j.schres.2007.01.029. [DOI] [PubMed] [Google Scholar]
  • 60.Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry. 1999;46:908–920. doi: 10.1016/s0006-3223(99)00152-3. [DOI] [PubMed] [Google Scholar]
  • 61.Andreasen NC, Paradiso S, O'Leary DS. ”Cognitive dysmetria” as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull. 1998;24:203–218. doi: 10.1093/oxfordjournals.schbul.a033321. [DOI] [PubMed] [Google Scholar]
  • 62.Harrison PJ. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 2004;174:151–162. doi: 10.1007/s00213-003-1761-y. [DOI] [PubMed] [Google Scholar]
  • 63.Harrison PJ, Eastwood SL. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus. 2001;11:508–519. doi: 10.1002/hipo.1067. [DOI] [PubMed] [Google Scholar]
  • 64.Zhou Y, Shu N, Liu Y, et al. Altered resting-state functional connectivity and anatomical connectivity of hippocampus in schizophrenia. Schizophr Res. 2008;100:120–132. doi: 10.1016/j.schres.2007.11.039. [DOI] [PubMed] [Google Scholar]
  • 65.Belujon P, Grace AA. Critical role of the prefrontal cortex in the regulation of hippocampus-accumbens information flow. J Neurosci. 2008;28:9797–9805. doi: 10.1523/JNEUROSCI.2200-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Heckers S, Heinsen H, Heinsen Y, Beckmann H. Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study. Biol Psychiatry. 1991;29:556–566. doi: 10.1016/0006-3223(91)90091-y. [DOI] [PubMed] [Google Scholar]
  • 67.Lauer M, Beckmann H. The human striatum in schizophrenia. I. Increase in overall relative striatal volume in schizophrenics. Psychiatry Res. 1997;68:87–98. doi: 10.1016/s0925-4927(96)02946-0. [DOI] [PubMed] [Google Scholar]
  • 68.Lauer M, Senitz D, Beckmann H. Increased volume of the nucleus accumbens in schizophrenia. J Neural Transm. 2001;108:645–660. doi: 10.1007/s007020170042. [DOI] [PubMed] [Google Scholar]
  • 69.Gray JA. Integrating schizophrenia. Schizophr Bull. 1998;24:249–266. doi: 10.1093/oxfordjournals.schbul.a033324. [DOI] [PubMed] [Google Scholar]
  • 70.Grace AA. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Brain Res Rev. 2000;31:330–341. doi: 10.1016/s0165-0173(99)00049-1. [DOI] [PubMed] [Google Scholar]
  • 71.Sim K, Cullen T, Ongur D, Heckers S. Testing models of thalamic dysfunction in schizophrenia using neuroimaging. J Neural Transm. 2006;113:907–928. doi: 10.1007/s00702-005-0363-8. [DOI] [PubMed] [Google Scholar]
  • 72.Velakoulis D, Wood SJ, Wong MT, et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry. 2006;63:139–149. doi: 10.1001/archpsyc.63.2.139. [DOI] [PubMed] [Google Scholar]
  • 73.Crow TJ, Ball J, Bloom SR, et al. Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry. 1989;46:1145–1150. doi: 10.1001/archpsyc.1989.01810120087013. [DOI] [PubMed] [Google Scholar]
  • 74.Shelton RC, Weinberger DR. X-ray computerized tomography studies in schizophrenia: a review and synthesis. In: Nasrallah HA, Weinberger DR, editors. The Neurology of Schizophrenia. New York, NY: Elsevier; 1986. pp. 207–250. [Google Scholar]
  • 75.Symonds LL, Archibald SL, Grant I, Zisook S, Jernigan TL. Does an increase in sulcal or ventricular fluid predict where brain tissue is lost? J Neuroimaging. 1999;9:201–209. doi: 10.1111/jon199994201. [DOI] [PubMed] [Google Scholar]
  • 76.Gaser C, Nenadic I, Buchsbaum BR, Hazlett EA, Buchsbaum MS. Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex. Am J Psychiatry. 2004;161:154–156. doi: 10.1176/appi.ajp.161.1.154. [DOI] [PubMed] [Google Scholar]
  • 77.Goldman-Rakic PS. Architecture of the prefrontal cortex and the central executive. Ann N Y Acad Sci. 1995;769:71–83. doi: 10.1111/j.1749-6632.1995.tb38132.x. [DOI] [PubMed] [Google Scholar]
  • 78.Andrade J. Working Memory in Perspective. Hove, England: UK Psychology Press; 2001. [Google Scholar]
  • 79.Walter H, Vasic N, Hose A, Spitzer M, Wolf RC. Working memory dysfunction in schizophrenia compared to healthy controls and patients with depression: evidence from event-related fMRI. NeuroImage. 2007;35:1551–1561. doi: 10.1016/j.neuroimage.2007.01.041. [DOI] [PubMed] [Google Scholar]
  • 80.Camchong J, Dyckman KA, Chapman CE, Yanasak NE, McDowell JE. Basal ganglia-thalamocortical circuitry disruptions in schizophrenia during delayed response tasks. Biol Psychiatry. 2006;60:235–241. doi: 10.1016/j.biopsych.2005.11.014. [DOI] [PubMed] [Google Scholar]
  • 81.Cannon TD, Glahn DC, Kim J, et al. Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory in patients with schizophrenia. Arch Gen Psychiatry. 2005;62:1071–1080. doi: 10.1001/archpsyc.62.10.1071. [DOI] [PubMed] [Google Scholar]
  • 82.Baddeley A, Hitch G. Working memory. In: Bower GH, editor. The Psychology of Learning and Motivation. New York, NY: Academic Press; 1974. pp. 47–89. [Google Scholar]
  • 83.Sturm W, Willmes K. On the functional neuroanatomy of intrinsic and phasic alertness. NeuroImage. 2001;14:S76–S84. doi: 10.1006/nimg.2001.0839. [DOI] [PubMed] [Google Scholar]
  • 84.Mitchell RL, Crow TJ. Right hemisphere language functions and schizophrenia: the forgotten hemisphere? Brain. 2005;128:963–978. doi: 10.1093/brain/awh466. [DOI] [PubMed] [Google Scholar]
  • 85.Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry. 1998;155:1711–1717. doi: 10.1176/ajp.155.12.1711. [DOI] [PubMed] [Google Scholar]
  • 86.Chua SE, Deng Y, Chen EY, et al. Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment. Psychol Med. 2008:1–8. doi: 10.1017/S0033291708004212. [DOI] [PubMed] [Google Scholar]
  • 87.Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49:1–52. doi: 10.1016/s0920-9964(01)00163-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Schizophrenia Bulletin are provided here courtesy of Oxford University Press

RESOURCES